Upload Avatar (500 x 500)
Yunzeng Zou
zou.yunzeng@zs-hospital.sh.cn
Chinese, Japanese, English
Shanghai
Fudan University
Biomedical Sciences
  • 1993.4-1997.3 PhD: Department of Cardiology, University of Tokyo
  • 1979.9-1984.8 Bachelor's: Department of Medicine, Peking University
  • National Outstanding Youth Science Fund, National Natural Science Foundation of China, 2006
  • Shanghai Outstanding Academic Leader, Shanghai Science and Technology Commission, 2005
  • 2004.9-present - Fudan University, Zhongshan Hospital - Professor
  • 2005.6-present - Fudan University, Zhongshan Hospital/Biomedical Research Institute - Professor (dual appointment)
  • 2000.4-2004.8 - University of Tokyo Medical School Cardiology and Chiba University Medical School Cardiology - Researcher
  • 1993.4-1997.3 - University of Tokyo Medical School Cardiology - Postdoctoral Fellow
  • 1984.9-1993.3 - Qingdao Medical College Affiliated Hospital Cardiology - Attending Physician
  • Shanghai Outstanding Overseas Chinese Person (2015): Shanghai Government
  • Huaxia Medical Third Prize (2014): Health Promotion Association
  • Chinese Medical Association Science and Technology Third Prize (2014): Chinese Medical Association
  • Shanghai Science and Technology Progress First Prize (2014): Shanghai Association for Science and Technology
  • Ministry of Education Science and Technology Progress Second Prize (2014): Ministry of Education
  • Shanghai Science and Technology Elite (2013): Shanghai Government
  • Shanghai Medical Science and Technology Second Prize (2012): Shanghai Medical Association
Cardiovascular System Internal Medicine Research
Hypertensive Myocardial Hypertrophy and Heart Failure Pathogenesis
Angiotensin Function Research
Gene and Cell Therapy for Ischemic Heart Disease
  • Mechanical stresses induce paracrine β-2 microglobulin from cardiomyocytes to activate cardiac fibroblasts through epidermal growth factor receptor., Li Y, Zhang X, Li L, Wang X, Chen Z, Wang X, Wang Y, Kang L, Ye Y, Jia J, Zhang G, Yang C, Yuan J, Zhou J, Ge J, Gong H, Zou Y., 2018
  • Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway., Yuan L, Qiu L, Ye Y, Wu J, Wang S, Wang X, Zhou N, Zou Y., 2018
  • MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress., Yuan J, Liu H, Gao W, Zhang L, Ye Y, Yuan L, Ding Z, Wu J, Kang L, Zhang X, Wang X, Zhang G, Gong H, Sun A, Yang X, Chen R, Cui Z, Ge J, Zou Y., 2018
  • HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis., Wang S, Wu J, You J, Shi H, Xue X, Huang J, Xu L, Jiang G, Yuan L, Gong X, Luo H, Ge J, Cui Z, Zou Y., 2018
  • Cardiomyocyte-Restricted Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) Deletion Leads to Lethal Dilated Cardiomyopathy Partly Through Drp1 Signaling., Chen Z, Li Y, Wang Y, Qian J, Ma H, Wang X, Jiang G, Liu M, An Y, Ma L, Kang L, Jia J, Yang C, Zhang G, Chen Y, Gao W, Fu M, Huang Z, Tang H, Zhu Y, Ge J, Gong H, Zou Y., 2018
  • Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload., You J, Wu J, Zhang Q, Ye Y, Wang S, Huang J, Liu H, Wang X, Zhang W, Bu L, Li J, Lin L, Ge J, Zou Y., 2018
  • Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin., Wo D, Peng J, Ren DN, Qiu L, Chen J, Zhu Y, Yan Y, Yan H, Wu J, Ma E, Zhong TP, Chen Y, Liu Z, Liu S, Ao L, Liu Z, Jiang C, Peng J, Zou Y, Qian Q, Zhu W., 2016
  • Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-α mediated NF-κB pathway., Gao W, Liu H, Yuan J, Wu C, Huang D, Ma Y, Zhu J, Ma L, Guo J, Shi H, Zou Y, Ge J., 2016
  • Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes., Sun Y, Kang L, Li J, Liu H, Wang Y, Wang C, Zou Y., 2016
  • The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice., Wang X, Ye Y, Gong H, Wu J, Yuan J, Wang S, Yin P, Ding Z, Kang L, Jiang Q, Zhang W, Li Y, Ge J, Zou Y., 2016
  • Mechanical Stress Regulates Endothelial Progenitor Cell Angiogenesis Through VEGF Receptor Endocytosis., Bai Y, Wang X, Shen L, Jiang K, Ding X, Cappetta D, Zhou J, Ge J, Zou Y., 2016
  • Exosomes derived from dendritic cells improve cardiac function via activation of CD4(+) T lymphocytes after myocardial infarction., Liu H, Gao W, Yuan J, Wu C, Yao K, Zhang L, Ma L, Zhu J, Zou Y, Ge J., 2016
  • Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress., Lin L, Liu X, Xu J, Weng L, Ren J, Ge J, Zou Y., 2016
  • High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway., Lin L, Liu X, Xu J, Weng L, Ren J, Ge J, Zou Y., 2015
  • Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study., Huang R, Yao K, Sun A, Qian J, Ge L, Zhang Y, Niu Y, Wang K, Zou Y, Ge J., 2015
  • Knockdown of nucleosome assembly protein 1-like 1 induces mesoderm formation and cardiomyogenesis via notch signaling in murine-induced pluripotent stem cells., Gong H, Yan Y, Fang B, Xue Y, Yin P, Li L, Zhang G, Sun X, Chen Z, Ma H, Yang C, Ding Y, Yong Y, Zhu Y, Yang H, Komuro I, Ge J, Zou Y., 2014
  • Olmesartan attenuates cardiac remodeling through DLL4tch1 pathway activation in pressure overload mice., You J, Wu J, Jiang G, Guo J, Wang S, Li L, Ge J, Zou Y., 2013
  • Comparison between adenosine and isoflurane for assessing the coronary flow reserve in mouse models of left ventricular pressure and volume overload., You J, Wu J, Ge J, Zou Y., 2012
Cardiovascular Internal Medicine Hypertension Myocardial Hypertrophy Heart Failure Angiotensin Gene Therapy Cell Therapy Ischemic Heart Disease Pathogenesis

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.